| RMFEX | VGICX | RMFEX / VGICX | |
| Total Expense Ratio | 0.62 | 1.44 | 43% |
| Annual Report Gross Expense Ratio | 0.62 | 1.49 | 42% |
| Fund Existence | 24 years | 29 years | - |
| Gain YTD | 9.694 | 15.495 | 63% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 250 | 1000 | 25% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 118B | 7.09B | 1,665% |
| Annual Yield % from dividends | 1.41 | 0.67 | 212% |
| Returns for 1 year | 9.45 | 19.09 | 50% |
| Returns for 3 years | 34.42 | 42.61 | 81% |
| Returns for 5 years | 39.25 | 50.68 | 77% |
| Returns for 10 years | 100.56 | 129.45 | 78% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| NMFAX | 17.66 | 0.12 | +0.68% |
| Nationwide BNY Mellon Dyn US Core A | |||
| VIDMX | 11.22 | 0.05 | +0.45% |
| Virtus KAR Developing Markets I | |||
| SCVNX | 43.20 | 0.01 | +0.02% |
| Allspring Small Company Value Inst | |||
| ASCRX | 19.75 | -0.01 | -0.05% |
| American Century Small Company R | |||
| FBIOX | 28.07 | -0.77 | -2.67% |
| Fidelity Select Biotechnology | |||